EBTATE Trademark

Trademark Overview

On Tuesday, May 18, 2021, a trademark application was filed for EBTATE with the United States Patent and Trademark Office. The USPTO has given the EBTATE trademark a serial number of 90718240. The federal status of this trademark filing is REGISTERED as of Tuesday, January 23, 2024. This trademark is owned by Molecular Targeting Technologies, Inc.. The EBTATE trademark is filed in the Pharmaceutical Products category with the following description:

Diagnostic radiopharmaceutical preparations
ebtate

General Information

Serial Number90718240
Word MarkEBTATE
Filing DateTuesday, May 18, 2021
Status700 - REGISTERED
Status DateTuesday, January 23, 2024
Registration Number7287801
Registration DateTuesday, January 23, 2024
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 6, 2022

Trademark Statements

Goods and ServicesDiagnostic radiopharmaceutical preparations

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, August 16, 2021
Primary Code005
First Use Anywhere DateMonday, April 8, 2019
First Use In Commerce DateTuesday, May 24, 2022

Trademark Owner History

Party NameMolecular Targeting Technologies, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressWest Chester, PA 19380
Party NameMolecular Targeting Technologies, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWest Chester, PA 19380
Party NameMolecular Targeting Technologies, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWest Chester, PA 19380

Trademark Events

Event DateEvent Description
Tuesday, January 23, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, January 23, 2024REGISTERED-PRINCIPAL REGISTER
Wednesday, December 20, 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, December 19, 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, December 19, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, December 19, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, December 19, 2023ASSIGNED TO LIE
Monday, July 24, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, June 20, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, June 20, 2023NON-FINAL ACTION E-MAILED
Tuesday, June 20, 2023SU - NON-FINAL ACTION - WRITTEN
Thursday, May 18, 2023STATEMENT OF USE PROCESSING COMPLETE
Friday, April 28, 2023USE AMENDMENT FILED
Wednesday, May 17, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, April 28, 2023TEAS STATEMENT OF USE RECEIVED
Tuesday, November 1, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 6, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 6, 2022PUBLISHED FOR OPPOSITION
Wednesday, August 17, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 2, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, August 2, 2022EXAMINER'S AMENDMENT ENTERED
Tuesday, August 2, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, August 2, 2022EXAMINERS AMENDMENT E-MAILED
Tuesday, August 2, 2022EXAMINERS AMENDMENT -WRITTEN
Wednesday, July 20, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, July 19, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, July 19, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, July 19, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, February 4, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, February 4, 2022NON-FINAL ACTION E-MAILED
Friday, February 4, 2022NON-FINAL ACTION WRITTEN
Thursday, January 27, 2022ASSIGNED TO EXAMINER
Monday, August 16, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, May 21, 2021NEW APPLICATION ENTERED

Related Keywords

ebtate preparations radiopharmaceutical diagnostic